Blair William & Co. IL Trims ResMed Inc. Stake

Institutional investor reduces position in medical equipment provider by 5.3%

Published on Mar. 8, 2026

Got story updates? Submit your updates here. ›

Blair William & Co. IL, an institutional investor, has trimmed its position in shares of ResMed Inc. (NYSE:RMD) by 5.3% during the third quarter, according to the company's recent Form 13F filing with the SEC. The investor now owns approximately 223,843 shares of the medical equipment provider's stock, valued at $61,273,000.

Why it matters

ResMed is a leading global medical device and cloud-connectivity company focused on improving outcomes for people with sleep-disordered breathing and chronic respiratory conditions. Changes in institutional ownership of the company's stock can provide insights into market sentiment and potential shifts in the stock's performance.

The details

According to the filing, Blair William & Co. IL sold 12,441 shares of ResMed stock during the third quarter. The institutional investor now owns approximately 0.15% of the company's outstanding shares. ResMed's stock price has fluctuated in recent months, with the share price ranging from a 52-week low of $199.92 to a high of $293.81.

  • The filing covers the third quarter of the year.
  • The shares were sold during the three-month period ending September 30, 2025.

The players

Blair William & Co. IL

An institutional investor that has trimmed its position in ResMed Inc. by 5.3% during the third quarter.

ResMed Inc.

A global medical device and cloud-connectivity company focused on improving outcomes for people with sleep-disordered breathing and chronic respiratory conditions.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Blair William & Co. IL's stake in ResMed could signal a shift in market sentiment towards the medical device company, though the overall institutional ownership remains significant at 54.98% of the company's shares. Investors will likely continue to monitor ResMed's financial performance and market position as it navigates the evolving healthcare landscape.